Gene · 8233
Papers1,303
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,303
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study. | PLoS One | 2026 | 42821569 | PubTator, text mining | PubMed |
| Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance. | Eur J Haematol | 2026 | 42728663 | PubTator, text mining | PubMed |
| Targeting splicing-derived neoantigens for precision cancer immunotherapy. | Front Immunol | 2026 | 42724627 | PubTator, text mining | PubMed |
| Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives. | Jpn J Clin Oncol | 2026 | 42704825 | PubTator, text mining | PubMed |
| Low-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings. | Radiol Case Rep | 2026 | 42668586 | PubTator, text mining | PubMed |
| Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients. | Br J Haematol | 2026 | 42630001 | PubTator, text mining | PubMed |
| Pervasive noise in human pre-mRNA splice site selection. | Mol Cell | 2026 | 42607686 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations. | J Clin Med | 2026 | 42590061 | PubTator, text mining | PubMed |
| Additional myelodysplasia-related gene mutations alter clinical presentation and worsen prognosis in patients with SRSF/TET2 co-mutated myeloid neoplasms. | Leuk Lymphoma | 2026 | 42584663 | PubTator, text mining | PubMed |
| The histopathological differential diagnosis of BPDCN and other plasmacytoid dendritic cell proliferations. | Virchows Arch | 2026 | 42563016 | PubTator, text mining | PubMed |
| Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia. | Leukemia | 2026 | 42443413 | PubTator, text mining | PubMed |
| Concurrent Loss of PIGA and ZRSR2 in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Neoplasm. | Int J Lab Hematol | 2026 | 42432858 | PubTator, text mining | PubMed |
| Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations. | Haematologica | 2026 | 42421623 | PubTator, text mining | PubMed |
| Rapid Transformation of Myelodysplastic Neoplasm to Myelodysplasia-related Acute Myeloid Leukemia with Central Nervous System Leukemia in a Young Adult. | Ann Afr Med | 2026 | 42252828 | PubTator, text mining | PubMed |
| Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience. | Ann Hematol | 2026 | 42249961 | PubTator, text mining | PubMed |
| In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines. | Prostate Cancer | 2026 | 42158898 | PubTator, text mining | PubMed |
| Loss of Chromosome Y Associates With Altered Immune Cell Trajectories and X-Inactivation Features. | Aging Cell | 2026 | 42070154 | PubTator, text mining | PubMed |
| A synergistic interaction between PRMT5 and LSD1 inhibitors in AML. | Sci Adv | 2026 | 41894488 | PubTator, text mining | PubMed |
| Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development. | Cancer Metastasis Rev | 2026 | 41894068 | PubTator, text mining | PubMed |
| [How I diagnose and treat chronic myelomonocytic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 41839624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8233/papers